What The Cannabis Industry Can Learn From Pharma With Martin Tindall, Phoenix Life Sciences
Jun 25, 2019
45:08
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Martin Tindall is the CEO and Director of Phoenix Life Sciences. He joins Rena Sherbill to discuss Phoenix's recently completed audits, federal deregulation, targeting diabetes treatment in the South Pacific and why branding should move away from old school imagery. Learn more about your ad choices. Visit megaphone.fm/adchoices
The Cannabis Investing Podcast